Project Details
Start Date
May 2024
Status
Closed to recruitment
Principal Investigator
Dr Gordon Duncan
NDN Study Lead
Jessica Crossan
Main Research Site
Western General Hospital
This clinical trial looks to see if Cannabidiol (CBD) is a safe and well-tolerated treatment for people with Parkinson’s Disease Psychosis.
What Happens In This Study?
You will either be given CBD or a placebo (a dummy pill that looks like the medicine but has no active ingredients). Neither you, nor the research team, will know which group you are in.
Can I Join This Study?
To take part in this medical trial, you must meet these 7 requirements:
- Your Diagnosis: A doctor must have confirmed that you have Parkinson’s disease.
- Your Age: You are 40 years old, or older.
- Your Symptoms: Your Parkinson’s symptoms include hallucinations and/or delusions that started after your diagnosis and have been going on for at least a week.
- Your Current Medicine: You must have been taking the same Parkinson’s medication for at least the last 1 month, without making any big changes to it.
- Your Study Partner: You must have a reliable friend of family member who knows you well and helps to care for you, who can also take part to provide us with information on how you are doing.
- Your Time: You must do your best to attend all your study visits, and follow the rules of the study until it ends.
- Taking the Medicine: You must be willing and able to swallow the trial medication.
Study Length: 18 weeks
Number of appointments: 6 visits, plus check in phone calls
More information on the trial can be found on the CAN-PDP website.
